Phase 2 Prostate Cancer Trial, Recruiting NCT06249750 Sponsor: Pengyuan Liu Condition: Prostate Cancer
Back to Prostate Cancer

Phase 2 Prostate Cancer Trial, Recruiting

NCT06249750
Recruiting Phase 2

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have been diagnosed with prostate cancer, confirmed by a tissue/biopsy test, and your cancer has stopped responding to hormone therapy (known as castration-resistant prostate cancer)
  • You have complete and reliable medical records available
  • You do not have any other primary (original) cancers besides this prostate cancer
  • Your blood tests, liver function, kidney function, and heart tests (ECG) are within a basically normal range
  • You are aged 18 years or older and under 90 years old, and you are able to carry out some daily activities (your doctor rates your physical ability as 0–3 on a standard scale)
  • You are willing and able to attend regular follow-up appointments as required by the trial

Who may not be able to join:

  • You have been diagnosed with another type of cancer (other than prostate cancer) within the past 5 years
  • Your blood test results are severely abnormal in a way that could put your safety at risk (confirm with trial site)
  • You have a serious ongoing health condition that means you could not safely tolerate the treatment being studied
  • You currently have an acute (sudden or active) illness, such as an active infection or active bleeding
  • You have recently taken part in another clinical trial and have not yet completed the required "washout period" (a waiting time between trials)
  • You are unable to tolerate being exposed to full-body heat stress — for example, if you suffer from claustrophobia (fear of enclosed spaces)
  • You have a known allergy to any of the medicines being used in this trial
  • Your doctor has another reason why joining this trial would not be appropriate for you (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
Phase 2: approximately ~30% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.
Phase success rates shown are historical industry-wide averages based on published data. They are not a prediction for this specific trial or your individual situation.

Contact this trial

Phone: 18368846455

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Phase 2
Sponsor
Pengyuan Liu
Registry
ClinicalTrials.gov
Start date
1 January 2024
Est. completion
31 December 2024

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Biochemical objective response rate (BORR)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov